Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
Tuch Steven L. | 0001957337 | Dec-08-2022 | officer: Chief Financial Officer |
Isaacsohn Jonathan | 0001943095 | Aug-09-2022 | director |
SEKHRI PAUL J | 0001264519 | Aug-01-2022 | director, officer: President and CEO |
Al-Marzooqi Fahed | 0001928247 | Jul-13-2022 | director |
Harris Keith R. | 0001742703 | Jul-11-2022 | director |
KOZLOV HERSH | 0001228774 | Jul-01-2022 | director |
Weiner Howard L. | 0001710056 | Jul-01-2022 | director |
Harjivan Chandresh | 0001932607 | Jun-01-2022 | director |
G42 Investments AI Holdings RSC Ltd. | 0001931913 | May-31-2022 | director, 10 percent owner |
Al-Nahyan Tahnoon Bin Zayed S. | 0001934660 | May-31-2022 | 10 percent owner |
Brown Barry K. | 0001903270 | Mar-29-2022 | officer: Chief Accounting Officer |
Nelson Rich S. | 0001833145 | Mar-03-2022 | director, officer: Acting Chief Executive Officer |
Prasad Deepa | 0001867165 | Oct-19-2021 | director, officer: President and CEO |
Abrams Robin Elizabeth | 0001671781 | Dec-30-2020 | director |
Taibi Edward P. | 0001820265 | Aug-31-2020 | director |
HOWARD RUDY | 0001108161 | Mar-10-2017 | officer: CFO & Secretary |
KINDLER JEFFREY B | 0001174454 | Mar-10-2017 | director, officer: Executive Chairman |
Holcombe Stephen L. | 0001648953 | Mar-10-2017 | officer: President & CEO |
Parker Craig C | 0001526064 | May-12-2016 | director |
FRY JOHN A | 0001255140 | Mar-16-2016 | director |
ALTSTIEL LARRY DOUGLAS | 0001619444 | Dec-01-2015 | officer: Chief Medical Officer |
Spiegel Noel Joseph | 0001513234 | Nov-19-2015 | director |
SAVAS PAUL G | 0001275756 | Sep-25-2015 | director |
PERELMAN RONALD O | 0001186472 | Sep-22-2015 | 10 percent owner |
MEISTER PAUL M | 0001033876 | Jul-30-2015 | director |
Cohen Steven Michael | 0001648881 | Jul-30-2015 | director |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by vTv Therapeutics Inc.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
8-K | Document | Current report filing Acc-no: 0001641489-24-000005 (34 Act) Size: 2678 KB |
Mar-05-2024 | 24718344 |
SC 13D | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001104659-24-031033 (34 Act) Size: 221 KB |
Mar-05-2024 | 24720869 |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001415889-24-005998 ( Act) Size: 7 KB |
Feb-29-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-005996 ( Act) Size: 7 KB |
Feb-29-2024 | |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001415889-24-005994 ( Act) Size: 4 KB |
Feb-29-2024 | |
8-K | Document | Current report filing Acc-no: 0001193125-24-049499 (34 Act) Size: 422 KB |
Feb-28-2024 | 24690710 |
424B5 | Document | Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0001193125-24-049449 (33 Act) Size: 324 KB |
Feb-28-2024 | 24690578 |
8-K | Document | Current report filing Acc-no: 0001193125-24-049260 (34 Act) Size: 666 KB |
Feb-28-2024 | 24690276 |
8-K | Document | Current report filing Acc-no: 0001641489-23-000088 (34 Act) Size: 146 KB |
Dec-22-2023 | 231510170 |
8-K | Document | Current report filing Acc-no: 0001641489-23-000085 (34 Act) Size: 145 KB |
Dec-19-2023 | 231497700 |
8-K | Document | Current report filing Acc-no: 0001641489-23-000082 (34 Act) Size: 145 KB |
Dec-12-2023 | 231481508 |
8-K | Document | Current report filing Acc-no: 0001641489-23-000079 (34 Act) Size: 150 KB |
Nov-20-2023 | 231423081 |
8-K | Document | Current report filing Acc-no: 0001641489-23-000076 (34 Act) Size: 153 KB |
Nov-15-2023 | 231409115 |
8-K | Document | Current report filing Acc-no: 0001641489-23-000074 (34 Act) Size: 2818 KB |
Nov-15-2023 | 231409110 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001641489-23-000070 (34 Act) Size: 6138 KB |
Nov-09-2023 | 231393066 |
8-K | Document | Current report filing Acc-no: 0001641489-23-000068 (34 Act) Size: 394 KB |
Nov-09-2023 | 231392798 |
8-K | Document | Current report filing Acc-no: 0001641489-23-000062 (34 Act) Size: 316 KB |
Nov-01-2023 | 231366656 |
DEF 14C | Document | Definitive information statements Acc-no: 0001641489-23-000059 (34 Act) Size: 138 KB |
Sep-25-2023 | 231276079 |
PRE 14C | Document | Preliminary information statement not related to a contested matter or merger/acquisition Acc-no: 0001641489-23-000056 (34 Act) Size: 138 KB |
Sep-15-2023 | 231258952 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001641489-23-000053 (34 Act) Size: 5682 KB |
Aug-11-2023 | 231164757 |
Recent 20 filings. View all vTv Therapeutics Inc. filings
Very good communication and delivery made within the timeframe I was advised of
It's being easier working on the website. And I recommend, it's a great website
Huge help thank you for your help .. y'all make it so much easier
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by